
LENSKART SOLUTIONS LTD (LENSKART): LENSKART Share Price Hits Fresh 52-Week High at Rs 629.70
Updated: 18 Aug 2026 • 1:09 pm
Posted by:

LENSKART Share Price rose 3.82% to Rs 629.55 and touched a fresh 52-week high of Rs 629.70. The stock’s market capitalisation stood at Rs 1,06,480.32 crore.
LENSKART Share Price traded at Rs 629.55 on 18 August 2026, up Rs 23.15 or 3.82% from the previous close of Rs 606.40, after touching a fresh 52-week high of Rs 629.70. The move places the company firmly on the radar of investors tracking Stocks in News, 52 Week High Stocks and Market Movers, while the market capitalisation stood at Rs 1,06,480.32 crore.
The supplied data confirms a clear one-year high event, strong intraday participation and a meaningful expansion over the prior close. What it does not establish is a company-specific catalyst. That matters because LENSKART Stock News today is being driven by a verified price event first: a fresh yearly high, strong turnover of Rs 268.68 crore and volume of 42,67,872 shares.
For investors following LENSKART Share Price Today, the relevance lies in three measurable points. First, the stock opened at Rs 607.55 and never materially slipped below Rs 606.70, showing buyers remained active through the session. Second, the stock climbed to Rs 629.70, its 52-week peak. Third, the valuation backdrop remains unusual, with a P/E ratio of 170.32, P/B ratio of 0.42, ROE of -2.89 and ROCE of -0.26. In this Univest analysis, the event is notable not just for the price action but also for how it contrasts with sector and peer metrics investors often monitor next.
LENSKART Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 629.55 |
| Previous Close | Rs 606.4 |
| Today's Change | +Rs 23.15 (+3.82%) |
| Day Open | Rs 607.55 |
| Fresh 52-Week High | Rs 629.7 |
| Day Low | Rs 606.7 |
| Current Volume | 42,67,872 |
| Turnover | Rs 268.68 crore |
| Market Capitalisation | Rs 1,06,480.32 crore |
LENSKART SOLUTIONS LTD (LENSKART) traded at Rs 629.55. versus the previous close of Rs 606.4, a rise of 3.82%. The stock opened at Rs 607.55, reached Rs 629.7, touched Rs 606.7. Reported volume was 42,67,872.
LENSKART Share Price Today reflects a strong session in which the stock moved higher from the open, held close to intraday lows, and reached a fresh 52-week high. The day’s numbers show firm price action, active trading value and sustained attention through the session.
LENSKART Share Price opened at Rs 607.55 against the previous close of Rs 606.40, indicating a mildly positive start. From there, the stock moved within a day range of Rs 606.70 to Rs 629.70 and was trading at Rs 629.55 at the time of the article. That left the stock just Rs 0.15 below the day high and exactly at the zone of its new 52-week peak.
The net gain of Rs 23.15 translated into a 3.82% rise for the day. In the context of Share Market Today and Stock Market Today screens, that kind of move becomes more relevant when it arrives with scale. Here, the scale came through in both volume and value: 42,67,872 shares changed hands, and turnover reached Rs 268.68 crore. Even without a confirmed company-specific trigger in the supplied data, the combination of a sharp day gain, a fresh one-year high and sizeable Trading Volume helps explain why LENSKART Share News is attracting attention.
Another feature of the session is how little downside emerged after the open. The stock’s day low of Rs 606.70 sat only marginally above the previous close, suggesting that the session’s directional bias remained positive for most of the day. For readers looking for a LENSKART Share Price Update, the verified takeaway is straightforward: the stock posted a decisive daily gain, printed a new yearly high and held near that high, which naturally shifts the discussion from simple price action to whether the fundamentals support continued market attention.
LENSKART SOLUTIONS LTD (LENSKART) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,06,480.32 crore |
| P/E Ratio | 170.32x |
| P/B Ratio | 0.42x |
| ROE | -2.89% |
| ROCE | -0.26% |
LENSKART SOLUTIONS LTD was valued at a P/E ratio of 170.32x, a P/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 170.32x |
| Benchmark Median P/E | 21x |
| Benchmark Average P/E | 49.19x |
| Benchmark P/E Range | 0x to 1,598.54x |
| Company P/B Ratio | 0.42x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 1,06,480.32 crore |
| Benchmark Median Market Cap | Rs 136.28 crore |
LENSKART SOLUTIONS LTD (LENSKART) is classified under sector: Healthcare.
LENSKART SOLUTIONS LTD (LENSKART) has a P/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
LENSKART SOLUTIONS LTD (LENSKART) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. LENSKART SOLUTIONS LTD (LENSKART) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,985.15 | 170.32 | 0.42 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,827.67 | 65.02 | 10.29 | 18.65 | 22.17 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,645.37 | 47.53 | 1.82 | -0.78 | 8.31 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,562.17 | 33.62 | 6.93 | -2.6 | 16.92 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,559.68 | 54.85 | 8.19 | 11.42 | 13.15 |
LENSKART SOLUTIONS LTD (LENSKART) has a P/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. LENSKART SOLUTIONS LTD (LENSKART) has a market capitalisation of Rs 1,06,480.32 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching LENSKART
The current focus on LENSKART Share Price is grounded in verified market data rather than an identified company-specific trigger. The stock is trending because the session combined a new 52-week peak with a solid daily gain and substantial turnover.
- Fresh price milestone: The stock touched Rs 629.70, marking a new 52-week high and putting it among notable 52 Week High Stocks and Stock Updates.
- Strong daily move: LENSKART Share Price Today was up 3.82%, or Rs 23.15, from the previous close of Rs 606.40.
- Active participation: Volume reached 42,67,872 shares and turnover stood at Rs 268.68 crore, underlining visible market interest.
- Large-company attention: The market capitalisation of Rs 1,06,480.32 crore makes it a large stock in the Indian Stock Market context.
- Valuation contrast: A P/E of 170.32 and P/B of 0.42 create an unusual valuation mix relative to the same-sector benchmark.
- Profitability watchpoint: ROE of -2.89 and ROCE of -0.26 place the stock below the sector’s median and average return ratios in the supplied data.
About LENSKART
LENSKART SOLUTIONS LTD is identified in the supplied market data under the symbol LENSKART and is classified within the Healthcare sector. The current event being tracked is a fresh 52-week high, recorded on 18 August 2026 at 12:55:34 PM IST, with the article published at 12:55:37 PM IST.
Based on the verified dataset used for this Univest article, the company is currently being followed primarily through its live market metrics rather than through an expanded business profile. Those market metrics include a current price of Rs 629.55, a 52-week peak of Rs 629.70 and a market capitalisation of Rs 1,06,480.32 crore. In practical terms, that means investor attention around LENSKART News Today is centred on the stock’s current price behaviour, valuation multiples and sector positioning. For readers looking for a compact Company Overview within this article, the most important confirmed facts are its listed identity, symbol and Healthcare classification, alongside the strong price action that has pushed the stock to a new one-year high.
Track LENSKART Share Price on Univest
Use LENSKART SOLUTIONS LTD (LENSKART) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors using Univest can track LENSKART Share Price through live price movements, 52-week levels, market-cap changes and valuation ratios such as P/E, P/B, ROE and ROCE. That makes Univest useful for monitoring both event-driven price action and deeper stock analysis in one place.
For readers following LENSKART Share Price Live, LENSKART Stock Performance and LENSKART Shareholding Pattern updates, Univest helps organise verified market data into a single view. In the current case, the biggest monitor points are whether the stock sustains levels near its fresh 52-week high, how its valuation continues to compare with Healthcare peers, and whether future company disclosures change the fundamental picture reflected in the supplied dataset.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest LENSKART Share Price Today?
Ans. LENSKART Share Price Today was Rs 629.55 at the time of this update. The stock was up Rs 23.15, or 3.82%, from the previous close of Rs 606.40 after touching a fresh 52-week high.
What is the fresh 52-week high for LENSKART?
Ans. The fresh 52-week high for LENSKART was Rs 629.70. The stock traded near that level at Rs 629.55, showing that the session’s strength remained largely intact after the one-year high was recorded.
Why is LENSKART Share Price rising today?
Ans. The supplied data confirms that LENSKART Share Price rose 3.82% and hit a fresh 52-week high, supported by volume of 42,67,872 shares and turnover of Rs 268.68 crore. It does not identify a company-specific catalyst.
How much did LENSKART gain in today’s session?
Ans. LENSKART gained Rs 23.15 in the session, which translated into a 3.82% increase over the previous close of Rs 606.40. The stock opened at Rs 607.55 and climbed as high as Rs 629.70.
What does today’s price range show for LENSKART?
Ans. The day range of Rs 606.70 to Rs 629.70 shows that LENSKART traded with a positive upward bias. The stock stayed close to the upper end of the range, indicating sustained interest through the session.
What is the market capitalisation of LENSKART?
Ans. LENSKART Market Cap stood at Rs 1,06,480.32 crore in the supplied data. That places it far above the Healthcare benchmark median of Rs 136.28 crore and average of Rs 468.36 crore.
Is LENSKART expensive compared with the Healthcare sector on P/E?
Ans. On the supplied numbers, LENSKART’s P/E ratio of 170.32 is well above the Healthcare sector median of 21 and the average of 49.19, placing it at a much higher earnings multiple than the benchmark.
How does LENSKART compare on P/B ratio?
Ans. LENSKART’s P/B ratio is 0.42, which is below the Healthcare sector median of 1.9 and average of 2.6. That means its book-based valuation is lower than the broader same-sector benchmark.
What do the ROE and ROCE figures indicate for LENSKART?
Ans. The supplied dataset shows ROE at -2.89 and ROCE at -0.26 for LENSKART. Both figures are below the Healthcare sector median and average, pointing to weaker reported return ratios than the benchmark.
Which sector does LENSKART belong to?
Ans. LENSKART is classified in the Healthcare sector in the supplied data. The sector benchmark used in this article covers 196 companies, allowing comparison across valuation, profitability and market-cap indicators. The stock belongs to the Healthcare sector.
Recent Articles

Multi Commodity Exchange Of India Ltd. (MCX) Share Price Rises 3.1% Today
18 August 2026

Radico Khaitan Ltd. (RADICO) Share Price Hits Fresh 52-Week High
18 August 2026

Welspun Corp Ltd. (WELCORP) Share Price Hits Fresh 52-Week High
18 August 2026

TD Power Systems Ltd. (TDPOWERSYS) Share Price Hits Fresh 52-Week High
18 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Multi Commodity Exchange Of India Ltd. (MCX) Share Price Rises 3.1% Today
Radico Khaitan Ltd. (RADICO) Share Price Hits Fresh 52-Week High
Welspun Corp Ltd. (WELCORP) Share Price Hits Fresh 52-Week High
TD Power Systems Ltd. (TDPOWERSYS) Share Price Hits Fresh 52-Week High
Data Patterns (India) Ltd. (DATAPATTNS) Share Price Rises 3.11% Today

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





